High-throughput diversification of protein-ligand surfaces to discover chemical inducers of proximity
Authors:
- James B. ShaumJSJames B. Shaum
- Miquel Muñoz i OrdoñoMOMiquel Muñoz i Ordoño
- Erica A. SteenESErica A. Steen
- Daniela V. WengeDWDaniela V. Wenge
- Hakyung CheongHCHakyung Cheong
- Moritz HunkelerMHMoritz Hunkeler
- Eric M. BilottaEBEric M. Bilotta
- Zoe RutterZRZoe Rutter
- Paige A. BartaPBPaige A. Barta
- Abby M. ThornhillATAbby M. Thornhill
- Lauren M. HargisLHLauren M. Hargis
Preprint
Abstract
Chemical inducers of proximity (CIPs) stabilize biomolecular interactions, often causing an emergent rewiring of cellular biochemistry. While rational design strategies can expedite the discovery of heterobifunctional CIPs, monovalent, molecular glue-like CIPs have relied predominantly on serendipity. Envisioning a prospective approach to discover molecular glues for a pre-selected target, we hypothesized that pre-existing ligands could be systematically decorated with chemical modifications to empirically discover protein-ligand surfaces that are tuned to cooperatively engage another protein interface. Here, we used sulfur(VI)-fluoride exchange (SuFEx)-based high-throughput chemistry (HTC) to install 3,163 structurally diverse chemical building blocks onto ENL and BRD4 ligands and then screened the crude products for degrader activity. This revealed dHTC1, a potent, selective, and stereochemistry-dependent degrader of ENL. It recruits CRL4 CRBN to ENL through an extended interface of protein-protein and protein-ligand contacts, but only after pre-forming the ENL:dHTC1 complex. We also characterized two structurally distinct BRD4 degraders, including dHTC3, a molecular glue that selectively dimerizes the first bromodomain of BRD4 to SCF FBXO3 , an E3 ligase not previously accessible for chemical rewiring. Altogether, this study introduces HTC as a facile tool to discover new CIPs and actionable cellular effectors of proximity pharmacology.Keywords
All Related Versions
- Published version: Nature Chemical Biology, 22 (9), 1.
Funding Information
- Ono Pharma Foundation (Breakthrough Science Initiative Awards Program)
- Donald E. and Delia B. Baxter Foundation (Young Investigator Award)
- Boehringer Ingelheim (Germany)
- Innovative Medicines Initiative 2 (875510)
- Austrian Academy of Sciences
- European Research Council (851478)
This publication has 90 references indexed in Scilit:
- Perfluorooxosulfate Salts as SOF4‐Gas‐Free Precursors to Multidimensional SuFEx ElectrophilesAngewandte Chemie International Edition, 2024
- Accelerating PROTACs Discovery Through a Direct‐to‐Biology Platform Enabled by Modular Photoclick ChemistryAdvanced Science, 2024
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Biocompatible SuFEx Click Chemistry: Thionyl Tetrafluoride (SOF4)‐Derived Connective Hubs for Bioconjugation to DNA and ProteinsAngewandte Chemie International Edition, 2019
- UCSF ChimeraX: Meeting modern challenges in visualization and analysisProtein Science, 2017
- Multidimensional SuFEx Click Chemistry: Sequential Sulfur(VI) Fluoride Exchange Connections of Diverse Modules Launched From An SOF4 HubAngewandte Chemie International Edition, 2017
- A set of baculovirus transfer vectors for screening of affinity tags and parallel expression strategiesAnalytical Biochemistry, 2009
- Investigations on the in vitro racemization of thalidomide by high-performance liquid chromatographyJournal of Chromatography A, 1994
- Shape Complementarity at Protein/Protein InterfacesJournal of Molecular Biology, 1993
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992